...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Quote from a January 19, 2021 review

,,,hummm,,I just answered KBC when he pointed out the news which was old news,,,,,,I get it a 3rd party has come out of the closet on it,,,,,,not sure why the peer reviewed data in the medical journals are not noted as being very much the same thing,,,,,,lets see,,,,,we can look back to see how much the market moved due to those publications,,,,,,have a lookie!!,,and tell us how important those reviews were to share price! Its just about stating and facing facts.

I really believe DMcC has never put his chunky monkey behind in a boardroom chair belonging to BP!

Nope,,,,,I dont drink his rheortic,,,,nor do I beleive RVX is 8 years ahead of all other research companies in respect to epigenetics....its just an opinion based on the NPV by Markets.....thats the only thing I have to go on,,,,as does everyone other investor. I will start getting out on the first pop if we are lucky enuff to get one....$1.50 would be a trigger pour moi.

Share
New Message
Please login to post a reply